Supplementary File 1 from PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with Myelofibrosis

• DOI: 10.1158/1078-0432.23626940.v1
• Publication Date: 2023-07-05T08:58:40Z
• Authors: Tamara K. Moyo; Ashwin Kishtagari; Matthew T. Villaume; Brandon McMahon; Sanjay R. Mohan; Tess Stopczynski; Sheau-Chiann Chen; Run Fan; Yuankai Huo; Hyeonsoo Moon; Yucheng Tang; Cosmin A. Bejan; Merrida Childress; Ingrid Anderson; Kyle Rawling; Rhea M. Simons; Ashley Moncrief; Rebekah Caza; Laura Dugger; Aunshka Collins; Channing V. Dudley; P. Brent Ferrell; Michael Byrne; Stephen A. Strick...; Gregory D. Ayers; Bennett A. Landman; Emily F. Mason; Ruben A. Mesa; Jeanne M. Palmer; Laura C. Michaelis; Michael R. Savona
• Keywords: Ruxolitinib

<p>Supplemental Tables S1-S9Supplemental Figures S1-S2</p>